We have located links that may give you full text access.
Characterization of extended-spectrum beta-lactamase-producing Salmonella isolates in a children's hospital in Ankara--first report of SHV-2a and SHV-9 in Salmonella spp. from Turkey.
Turkish Journal of Pediatrics 2009 January
The rate of in vitro resistance to various antimicrobials in 179 consecutive isolates of Salmonella spp., which included serogroups D (109), B (52), C1 (10) and C2 (8) isolated from children, was investigated. Production of extended-spectrum beta-lactamase (ESBL) was studied in ampicillin-resistant isolates. Antimicrobial susceptibilities were determined by disk diffusion tests and by BIOMIC video reader system. Overall resistance rates to ampicillin and amoxicillin/clavulanate were 26.3% and 10.6%, respectively. Resistance to ceftriaxone and ceftazidime was 3.3%. Resistance rates for chloramphenicol, trimethoprim-sulfamethoxazole, ciprofloxacin, amikacin and gentamicin were 40.7%, 31.3%, 2.2%, 2.2% and 6.1%, respectively. beta-lactamase production was detected in 42 isolates. Mating out experiments, isoelectric focusing, dot blot hybridization, polymerase chain reaction (PCR) and sequencing were performed on two S. paratyphi B isolates that produced ESBLs. One isolate produced SHV-2 and TEM-1 and the other produced SHV-2a, SHV-5a (SHV-9) and TEM-1. This is the first report of SHV-2a and SHV-5a (SHV-9) in S. paratyphi B in Turkey.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app